New award for human insulin with novo nordisk, INC. Period of performance is 7/1/2020 - 6/30/2021 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0018
- Awardee
-
Novo Nordisk Inc. UEI W72BJMJYBMN3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- Human Insulin Pre-Solicitation · 36E79720R0010 · Posted Dec 16, 2019
- 6505--Human Insulin Effective 7/1/2020 - 6/30/2021 Award Notice · Posted Mar 12, 2020
- Human Insulin (Amendment to add NDC and NDA/ANDA Number Entries on the Continuation of Standard Form 1449) Solicitation · Posted Jan 6, 2020
- Last date to order 100% complete
- IDV ceiling
- $470,487,013.27
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal government has awarded Novo Nordisk Inc., a global healthcare company, an Indefinite Delivery Contract (IDC) worth up to $470,487,013.27 to supply various types of human insulin. The single-award IDC was issued by the Department of Veterans Affairs' (VA) National Acquisition Center and has a period of performance from July 1, 2020 to June 30, 2025, with a one-year base period and four one-year option periods.
The IDC aims to ensure an uninterrupted, cost-effective supply of critical insulin medications for federal health programs, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract covers a range of insulin products in vial and disposable pen packaging, including Human R, Human N, Human 70/30, short-acting/intermediate analog mixes, and short-acting analog insulins. The total estimated annual requirements across the two product groups exceed 5 million units. Novo Nordisk, as the prime contractor, will leverage its manufacturing capabilities to fulfill task orders placed under the IDC for distribution to federal hospitals, clinics, and other healthcare facilities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 17
Quick answers
Who was awarded contract 36E79720D0018?
36E79720D0018 was awarded to Novo Nordisk Inc. by National Acquisition Center (Headquarters) on July 1, 2020.
How much is contract 36E79720D0018 worth?
36E79720D0018's own ceiling is $470,487,013.
Who can order from contract 36E79720D0018?
36E79720D0018 is a single award indefinite delivery contract.
Was contract 36E79720D0018 competed?
The extent of competition for 36E79720D0018 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV